Press "Enter" to skip to content

Patent delisted for Daiichi Sankyo drug BENICAR

0
Copyright © DrugPatentWatch. Originally published at Patent delisted for Daiichi Sankyo drug BENICAR

Annual Drug Patent Expirations for BENICAR
Benicar is a drug marketed by Daiichi Sankyo and is included in two NDAs. It is available from three suppliers.

BENICAR drug price trends.

Drug patent litigation for BENICAR.

The generic ingredient in BENICAR is hydrochlorothiazide; olmesartan medoxomil. Three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; olmesartan medoxomil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at Patent delisted for Daiichi Sankyo drug BENICAR
DrugPatentWatch - Make Better Decisions